Paradoxical Lucidity in Severe End-Stage Dementia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Paradoxical Lucidity in Severe End-Stage Dementia — Stella

View on ClinicalTrials.gov

Recruiting

Back to Dementia trials

Trial locations(1 site)

United States

NYU Langone Health, New York, New York

Key details

Sponsor

NYU Langone Health

Collaborators

National Institute on Aging (NIA)

Enrollment target

~520 participants

Started

June 2022

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.